Diagnostics Inc expected to post a loss of 34 cents a share - Earnings Preview

Co-Diagnostics

10/03/2025 11:03

Co-Diagnostics Inc CODX.OQ CODX.O is expected to show a fall in quarterly revenue when it reports  results on March 12 (estimated) for the period ending December 31 2024

The Salt Lake City Utah-based  company is expected to report a 89.5% decrease in revenue to $375 thousand from $3.56 million a year ago, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Co-Diagnostics Inc is for a loss of 34 cents per share.

The one available analyst rating on the shares is "hold".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Co-Diagnostics Inc is $1.50​, above​ its last closing price of $0.56. ​​​

This summary was machine generated March 10 at 11:03 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)